Auditory evoked potentials in young patients with Down syndrome. Event- related potentials (P3) and histaminergic system

Cognitive Brain Research

Volumn 5, Issue 4, 1997, Pages 301-309

  Seidl, Rainer ^a   Hauser, Erwin ^a   Bernert, Günther ^a   Marx, Manfred ^a   Freilinger, Michael ^a   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Auditory event related potential; Brainstem auditory evoked potential; Child; Down syndrome; Histamine; P3; Pheniramine

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; PHENIRAMINE;

ADOLESCENT; ADULT; AMPLITUDE MODULATION; ANTICHOLINERGIC EFFECT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOWN SYNDROME; EVOKED AUDITORY RESPONSE; EVOKED BRAIN STEM RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; LATENT PERIOD; MALE; NEUROCHEMISTRY; NORMAL HUMAN; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; DOWN SYNDROME; EVOKED POTENTIALS, AUDITORY; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; PHENIRAMINE; REFERENCE VALUES;

EID: 0030922126     PISSN: 09266410     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-6410(97)00008-6     Document Type: Article

References (69)

1. Barnet A.B., Lodge A. Click evoked EEG responses in normal and developmentally retarded infants. Nature. 214:1967;252-255.
2. Becker L.E., Armstrong D.L., Chan F. Dendritic atrophy in children with Down's syndrome. Ann. Neurol. 20:1986;310-313.
3. Bekkers J.M. Enhancement by histamine of NMDA-mediated synaptic transmission in the hippocampus. Science. 261:1993;104-106.
4. Blackwood D.H.R., St. Clair D.M., Muir W.J., Oliver C.J., Dickens P. The development of Alzheimer's disease in Down's syndrome assessed by auditory event-related potentials. J. Ment. Defic. Res. 32:1988;439-453.
5. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
6. Callner D.A., Dustman R.E., Madsen J.A., Schenkenberg T., Beck E.C. Life span changes in the average evoked responses of Down's syndrome and nonretarded persons. Am. J. Ment. Defic. 82:1978;398-405.
7. Chen Y.-J., Kang W.-M., So W.C.-M. Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: a psychometric and neurophysiological study. Epilepsia. 37:1996;81-86.
8. Conners C.K., Reader M., Reiss A., Caldwell J., Caldwell L., Adesman A., Mayer L., Berg M., Clymer R., Erwin R. The effects of piracetam upon visual event-related potentials in dyslexic children. Psychophysiology. 24:1987;513-521.
9. Courchesne E., Kilman B.A., Galambos R., Lincoln A.J. Autism: processing of novel auditory information assessed by event-related brain potentials. Electroenceph. Clin. Neurophysiol. 59:1984;238-248.
10. E. Courchesne, Physioanatomical consideration in Down syndrome, in: L. Nadel (Ed.), The Psychobiology of Down Syndrome, MIT Press, Cambridge, MA, 1988, 291 pp.
11. De Almeida M.A.M.R., Izquiero I. Intracerebroventricular histamine but not 48/80 causes posttraining memory facilitation in the rat. Arch. Int. Pharmacodyn. 291:1988;202-207.
12. Diaz F., Zurron M. Auditory evoked potentials in Down's syndrome. Electroenceph. Clin. Neurophysiol. 96:1995;526-537.
13. Dustman R.E., Callner D.A. Cortical evoked responses and response decrement in nonretarded and Down's syndrome individuals. Am. J. Ment. Defic. 83:1979;391-397.
14. C.J. Epstein, Down syndrome (Trisomy 21), in: S.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, New York, 1995, pp. 749-794.
15. Finley W.W., Faux S.F., Hutcheson J., Amstutz L. Long-latency event-related potentials in the evaluation of cognitive function in children. Neurology. 35:1985;323-327.
16. Folsom R.C., Widen J.E., Wilson W.R. Auditory brain stem responses in infants with Down's syndrome. Arch. Otolaryngol. Head Neck Surg. 109:1983;607-610.
17. A.E. Fowler, Language abilities in children with Down syndrome: evidence for a specific syntactic delay, in: D. Cicchetti, M. Beeghly (Eds.), Children with Down Syndrome, Cambridge University Press, New York, 1990, pp. 302-328.
18. Friedman D., Brown C., Vaughan H.G., Cornblatt B., Erlenmeyer-Kimling L. Cognitive brain potential components in adolescents. Psychophysiology (Berlin). 21:1984;83-96.
19. Fuchigami T., Okubo O., Fujita Y., Okuni M., Noguchi Y., Yamada T. Auditory event-related potentials and reaction time in children: evaluation of cognitive development. Dev. Med. Child Neurol. 35:1993;230-237.
20. Goodin D.S., Aminoff M.J. Electrophysiological differences between subtypes of dementia. Brain. 109:1986;1103-1113.
21. J.P. Green, Histamine, in: G.J. Siegel, W. Agranoff, R.W. Albers, P.B. Molinoff (Eds.), Basic Neurochemistry, Raven Press, New York, 1994, pp. 309-320.
22. Gulat-Marnay C., Lafitte A., Arrang J.M., Schwartz J.C. Regulation of histamine release and synthesis in the brain by muscarinic receptors. J. Neurochem. 52:1989;248-254.
23. Hansenne M., Pitchot W., Moreno A.G., Papart P., Timsit-Berthier M., Ansseau M. Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines). Electroenceph. Clin. Neurophysiol. 96:1995;194-196.
24. Haxby J.V. Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in nondemented old adults. J. Ment. Defic. Res. 33:1989;193-200.
25. Hillyard S.A. Electrical and magnetic brain recordings: contributions to cognitive neuroscience. Curr. Opin. Neurobiol. 3:1993;217-224.
26. Ito J., Yamoa S., Fukuda H., Mimori Y., Nakamura S. The P300 event-related potentials in dementia of the Alzheimer type. Correlations between P300 and monoamine metabolites. Electroenceph. Clin. Neurophysiol. 77:1990;174-178.
27. Jiang Z.D., Wu Y.Y., Liu X.Y. Early development of brainstem auditory evoked potentials in Down's syndrome. Early Hum. Dev. 23:1990;41-51.
28. Kaga K., Marsh R.R. Auditory brainstem responses in young children with Down's syndrome. Int. J. Pediat. Otorhinolaryngol. 11:1986;29-38.
29. Kakigi R., Kuroda Y. Brain-stem auditory evoked potentials in adults with Down's syndrome. Electroenceph. Clin. Neurophysiol. 84:1992;293-295.
30. Kamei C., Okumura Y., Tasaka K. Influence of certain H1 blockers on the step-through active avoidance response in rats. Psychopharmacology (Berlin). 102:1990;312-318.
31. Kamei C., Okumura Y., Tasaka K. Influence of histamine depletion on learning and memory recollection in rats. Psychopharmacology (Berlin). 111:1993;376-382.
32. R. Karrer, J. Ivins, Event-related slow potentials in mental retardates, in: W.C. McCallum, J.R. Knott (Eds.), The Responsive Brain, Wright, Bristol, 1976, pp. 154-157.
33. Kerr J.S., Dunmore C., Hindmarch I. The psychomotor and cognitive effects of new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy voluteers. Eur. J. Clin. Pharmacol. 47:1994;331-335.
34. Kish S., Karlinsky H., Becker L., Gilbert J., Rebbetoy M., Chang L.-J., Di Stefano L., Hornykiewicz O. Down's syndrome individuals begin life with normal levels of brain cholinergic markers. J. Neurochem. 52:1989;1183-1187.
35. Klorman R., Brumaghim J.T., Fitzpatrick P.A., Borgstedt A.D. Methylphenidate speeds evaluation processes of attention deficit disorder adolescents during a continuous performance test. J. Abnorm. Child Psychol. 19:1991;263-283.
36. Knight R.T., Scabini D., Woods D.L., Clayworth C. Contributions of the temporal-parietal junction to the human auditory P3. Brain Res. 13:1989;109-116.
37. Kropotov J.D., Ponomarev V.A. Subcortical neuronal correlates of component P300 in man. Electroenceph. Clin. Neurophysiol. 78:1991;40-49.
38. A.J. Lincoln, E. Courchesne, B.A. Kilman, R. Galambos, Auditory ERPs and information processing in Down's syndrome children, in: W.C. McCallum, R. Zappoli, F. Denoth (Eds.), Cerebral Psychophysiology: Studies in Event-Related Potentials. Electroenceph. Clin. Neurophysiol. Suppl. 38, Elsevier, Amsterdam, 1986, pp. 492-495.
39. Martinez-Mir M.I., Pollard H., Moreau J., Arrang J.M., Ruat M., Traiffort E., Schwartz J.C., Palacios J.M. Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. Brain Res. 526:1990;322-327.
40. Maurer K., Riederer P., Heinsen H., Beckmann H. Altered P300 topography due to functional and structural disturbances in the limbic system in dementia and psychosis and to pharmacological conditions. Psychiat. Res. 29:1989;391-393.
41. Meador K.J., Loring D.W., Davis H.C., Setli K.D., Patel B.R., Adams R.J. Cholinergic and serotonergic effects on the P3 potential and recent memory. J. Clin. Exp. Neuropsychol. 11:1989;252-260.
42. Melyn M.A., White D.T. Mental and developmental milestones of noninstitutionalized Down's syndrome children. Pediatrics. 52:1973;542-548.
43. Miyazaki S., Imaizumi M., Onondera K. Ameliorating effects on scopolamine-induced learning deficits using an elevated plus-maze test in mice. Life Sci. 56:1995;1563-1570.
44. Morris R.G.M., Amaral D.G., Mishkin M. Cognitive neuroscience. Editorial overview. Curr. Opin. Neurobiol. 5:1995;137-140.
45. L. Nadel, C.J. Epstein (Eds.), Progress in Clinical and Biological Research. Vol. 379. Down Syndrome and Alzheimer Disease, Wiley-Liss, New York, 1992, p. xiii.
46. Naganuma Y., Konishi T., Hongou K., Murakami M., Yamatani M., Yagi S., Okada T. Auditory event-related potentials in benign childhood epilepsy with centrotemporal spike: the effects of carbamazepin. Clin. Electroencephalogr. 25:1994;8-12.
47. Ortiz Alonso T., Navarro M., Vila Abad E. P300 component of the auditory event-related potentials and dyslexia. Funct. Neurol. 5:1990;333-338.
48. J.A. Pineda, D. Swick, S.L. Foote, Noradrenergic and cholinergic influences on the genesis of P3-like potentials, in: C.H.M. Brunia, G. Mulder and M.N. Verbaten (Eds.), Event-Related Research. Electroenceph. Clin. Neurophysiol., Suppl. 42, Elsevier, Amsterdam, 1991, pp. 165-172.
49. Polich J. P300 in clinical applications: meaning, method, and measurement. Am. J. EEG Technol. 31:1991;201-231.
50. Prast H., Fischer H., Philippu A. Release of acetylcholine in the ventral striatum is influenced by histamine receptors. Agents Actions. 41:1994;C85-C86.
51. Roizen N.J., Wolters C., Nicol T., Blondis T.A. Hearing loss in children with Down syndrome. J. Pediat. 1:1993;S9-S12.
52. Roncagliolo M., Benitez J., Perez M. Auditory brainstem responses of children with developmental language disorders. Dev. Med. Child Neurol. 36:1994;26-33.
53. Rosenberg C., Nudleman K., Starr A. Cognitive evoked potentials (P300) in early Huntington's disease. Arch. Neurol. 42:1985;984-987.
54. Satterfield J.H., Schell A.M., Nicholas T.W., Satterfield B.T., Freese T.E. Ontogeny of selective attention effects on event-related potentials in attention-deficit hyperactivity disorder and normal boys. Biol. Psychiat. 28:1990;879-903.
55. Schafer E.W.P., Peeke H.V.S. Down syndrome individuals fail to habituate cortical evoked potentials. Am. J. Ment. Defic. 87:1982;332-337.
56. C. Schneider, E. Kitzmueller, D. Risser, N. Cairns, H. Prast, N. Singewald, G. Lubec, Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease, Neurosci. Lett., 222 (1997) 183-186.
57. J.C. Schwartz, H.L. Haas (Eds.), The Histamine Receptor, Wiley-Liss, New York, 1992, 16 pp.
58. Sersen E.A., Heaney G., Clausen J., Belser R., Rainbow S. Brainstem auditory-evoked responses with and without sedative in autism and Down's syndrome. Biol. Psychiat. 27:1990;834-840.
59. Shibasaki H., Miyazaki M. Event-related potential studies in infants and children. J. Clin. Neurophysiol. 9:1992;408-418.
60. Smith M.E., Halgren E., Sokolik M., Bauden P., Musoloin A., Liégeois-Chauvel C., Chauvel P. The intracranial topography of the P3 event-related potential elicited during auditory oddball. Electroenceph. Clin. Neurophysiol. 76:1990;235-248.
61. Squires N., Ollo C., Jordan R. Auditory brain stem responses in the mentally retarded: audiometric correlates. Ear Hear. 7:1986;83-92.
62. N.K. Squires, G.C. Galbright, C.J. Aine, Event related potential assessment of sensory and cognitive deficits in the mentally retarded, in: D. Lehmann, D. Callaway (Eds.), Human Evoked Potentials, Plenum, New York, 1979, pp. 397-413.
63. St. Clair D.F., Blackwood D. Premature senility in Down's syndrome. Lancet. 2:1985;34.
64. Stazione P., Fattaposta F., Giunti P., D'Alessio C., Tagliati M., Affricano C., Amabile G. P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300. Electroenceph. Clin. Neurophysiol. 80:1991;446-453.
65. Sunaga Y., Hikima A., Otsuka T., Nagashima K., Kuroume T. P300 event-related potentials in epileptic children. Clin. Electroencephalogr. 25:1994;13-17.
66. Vieregge P., Verleger R., Schulze-Rava H., Kömpf D. Late cognitive event-related potentials in adult Down's syndrome. Biol. Psychiat. 32:1992;1118-1134.
67. Vuurman E.F., Uiterwijk M.M., Rosenzweig P., O'Hanlon J.F. Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. Eur. J. Clin. Pharmacol. 47:1994;253-259.
68. Wisniewski K.E. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am. J. Med. Genet. Suppl. 7:1990;274-281.
69. Wisniewski K.E., Wisniewski H.M., Wen G.Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down syndrome. Ann. Neurol. 17:1985;278-282.